Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Insights into the Novel Biomarkers Expressed in Diabetic Nephropathy: Potential Clinical Applications

17 Oct 2024

Abstract excerpt

Diabetic nephropathy (DN) is increasing worldwide in parallel with type 2 diabetes mellitus. Identifying diagnostic biomarkers for DN at an early stage is crucial due to the considerable societal and economic burden associated with diabetes mellitus (DM) and its risk factors. In the past, early indicators of microvascular problems, such as microalbuminuria (MA), have been used to predict the possibility of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Kidney Disease and Diabetes
Share to Dialysis and Renal Disease Management
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39415582
DOI: 10.2174/0113816128333694240928161703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Insights into the Novel Biomarkers Expressed in Diabetic Nephropathy: Potential Clinical ApplicationsPMID 39415582Read ↗

Biomarkers of Diabetic Nephropathy, the Present and the FutureSemantic proximity Read ↗

Expression and diagnostic value evaluation of urinary exosomal miR-142-3p in diabetic nephropathySemantic proximity Read ↗

The Potential of Albuminuria as a Biomarker of Diabetic Complications.Semantic proximity Read ↗

Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy.Semantic proximity Read ↗

MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetesSemantic proximity Read ↗

Biomarkers of Fabry Nephropathy: Review and Future PerspectiveSemantic proximity Read ↗

Urine Proteomics Identifies Biomarkers for Diabetic Kidney Disease at Different StagesSemantic proximity Read ↗

Diabetic nephropathy: a frontier for personalized medicine.Semantic proximity Read ↗

Diabetic nephropathy.Semantic proximity Read ↗

Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.Semantic proximity Read ↗

Advances in the Epigenetic Mechanisms of Diabetic Nephropathy PathogenesisSemantic proximity Read ↗

Role of Exosomal miRNAs and Epigenetic Modifications in Diabetic Nephropathy: Insights into Novel Diagnostic and Therapeutic StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.